{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:16:37Z","timestamp":1767626197063,"version":"3.30.1"},"reference-count":36,"publisher":"Bentham Science Publishers Ltd.","issue":"39","funder":[{"name":"Turkish Rheumatology Association","award":["2023\/015"],"award-info":[{"award-number":["2023\/015"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>The clinical symptoms and laboratory markers of Rheumatoid Arthritis\n(RA) and Psoriatic Arthritis (PsA) can be very similar, so making a differential diagnosis\nbetween these two diseases is often difficult. Serological parameters to be used in differential\ndiagnosis can guide the clinician. This study aimed to investigate the usability\nof 14-3-3\u03b7 (eta) protein as a biomarker in the differential diagnosis of PsA and RA, and\nthe relationships between eta protein and disease activity scores and joint erosions in\nPsA and RA.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>54 PsA patients, 53 RA patients, and 56 healthy individuals were included in\nthis study. The ELISA (Enzyme-Linked ImunoSorbent Assay) kit was used as a quantitative\nsandwich enzyme immunoassay technique to detect human eta protein levels. Receiver-\noperating Characteristic (ROC) curves analysis was used to determine the sensitivity\nand specificity of the eta protein.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Eta protein levels were found to be significantly higher in the RA group than in\nthe PsA [B: -0.341, OR (95% CI): 0.711 (0.556-0.909), p: 0.007] and control [B: -0.225,\nOR (95% CI): 0.798 (0.641-0.995), p: 0.045] groups. Eta protein median values were significantly\nhigher in patients with joint erosion than in those without [\u03b2= 0.151, OR (95%\nCI): 1.163 (1.003-1.349), p: 0.046].<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Eta protein levels are higher in the serum of RA patients than PsA and are\nassociated with joint erosion. Eta protein may be a potential biomarker in the differential\ndiagnosis of RA and PsA. It may represent a possible therapeutic step in the pathophysiological\npathways in the development of joint erosion.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673295359240422115759","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T06:20:23Z","timestamp":1714458023000},"page":"6510-6520","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Does Eta Protein Differentiate Rheumatoid Arthritis from Psoriatic Arthritis?"],"prefix":"10.2174","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5794-6951","authenticated-orcid":true,"given":"Ahmet","family":"Kor","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Aksaray Training and Research Hospital, Aksaray, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevser","family":"Orhan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ankara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y\u00fcksel","family":"Mara\u015f","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of\nHealth Sciences, Ankara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra F\u0131rat","family":"O\u011fuz","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry,\nAnkara Bilkent City Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehtap Kal\u00e7\u0131k","family":"Unan","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation Division\nof Rheumatology, Faculty of Medicine, Sakarya University, Sakarya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamze","family":"Dilek","sequence":"additional","affiliation":[{"name":"Department of Rheumatology,\nFaculty of Medicine, Bolu Izzet Baysal University, Bolu, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015e\u00fckran","family":"Erten","sequence":"additional","affiliation":[{"name":"Department of Rheumatology,\nAnkara Bilkent City Hospital, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Nas","sequence":"additional","affiliation":[{"name":"Department of Physical\nMedicine and Rehabilitation Division of Rheumatology and Immunology, Faculty of Medicine, Sakarya University,\nSakarya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"Ritchlin C.T.","year":"2017","unstructured":"Ritchlin C.T.; Colbert R.A.; Gladman D.D.; Psoriatic Arthritis. N Engl J Med  2017,376(10),957-970","journal-title":"N Engl J Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"Smolen J.S.","year":"2017","unstructured":"Smolen J.S.; Landew\u00e9 R.; Bijlsma J.; Burmester G.; Chatzidionysiou K.; Dougados M.; Nam J.; Ramiro S.; Voshaar M.; van Vollenhoven R.; Aletaha D.; Aringer M.; Boers M.; Buckley C.D.; Buttgereit F.; Bykerk V.; Cardiel M.; Combe B.; Cutolo M.; van Eijk-Hustings Y.; Emery P.; Finckh A.; Gabay C.; Gomez-Reino J.; Gossec L.; Gottenberg J.E.; Hazes J.M.W.; Huizinga T.; Jani M.; Karateev D.; Kouloumas M.; Kvien T.; Li Z.; Mariette X.; McInnes I.; Mysler E.; Nash P.; Pavelka K.; Po\u00f3r G.; Richez C.; van Riel P.; Rubbert-Roth A.; Saag K.; da Silva J.; Stamm T.; Takeuchi T.; Westhovens R.; de Wit M.; van der Heijde D.; EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis  2017,76(6),960-977","journal-title":"Ann Rheum Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/0004563217733500","volume":"55","author":"Knani I.","year":"2018","unstructured":"Knani I.; Bouzidi H.; Zrour S.; Bergaoui N.; Hammami M.; Kerkeni M.; Increased serum concentrations of N  -carboxymethyllysine are related to the presence and the severity of rheumatoid arthritis. Ann Clin Biochem  2018,55(4),430-436","journal-title":"Ann Clin Biochem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1515\/cclm-2022-0244","volume":"60","author":"Van Hoovels L.","year":"2022","unstructured":"Van Hoovels L.; Vander Cruyssen B.; Sieghart D.; Bonroy C.; Nagy E.; Pullerits R.; \u010cu\u010dnik S.; Dahle C.; Heijnen I.; Bernasconi L.; Benkhadra F.; Bogaert L.; Van Den Bremt S.; Van Liedekerke A.; Vanheule G.; Robbrecht J.; Studholme L.; Wirth C.; M\u00fcller R.; Kyburz D.; Sj\u00f6wall C.; Kastbom A.; Je\u0161e R.; Jovancevic B.; Kiss E.; Jacques P.; Aletaha D.; Steiner G.; Verschueren P.; Bossuyt X.; IgA rheumatoid factor in rheumatoid arthritis. Clin Chem Lab Med  2022,60(10),1617-1626","journal-title":"Clin Chem Lab Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-020-0168-y","volume":"6","author":"Smolen J.S.","year":"2020","unstructured":"Smolen J.S.; Rheumatoid arthritis Primer  behind the scenes. Nat Rev Dis Primers  2020,6(1),32","journal-title":"Nat Rev Dis Primers"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"Smolen J.S.","year":"2020","unstructured":"Smolen J.S.; Landew\u00e9 R.B.M.; Bijlsma J.W.J.; Burmester G.R.; Dougados M.; Kerschbaumer A.; McInnes I.B.; Sepriano A.; van Vollenhoven R.F.; de Wit M.; Aletaha D.; Aringer M.; Askling J.; Balsa A.; Boers M.; den Broeder A.A.; Buch M.H.; Buttgereit F.; Caporali R.; Cardiel M.H.; De Cock D.; Codreanu C.; Cutolo M.; Edwards C.J.; van Eijk-Hustings Y.; Emery P.; Finckh A.; Gossec L.; Gottenberg J.E.; Hetland M.L.; Huizinga T.W.J.; Koloumas M.; Li Z.; Mariette X.; M\u00fcller-Ladner U.; Mysler E.F.; da Silva J.A.P.; Po\u00f3r G.; Pope J.E.; Rubbert-Roth A.; Ruyssen-Witrand A.; Saag K.G.; Strangfeld A.; Takeuchi T.; Voshaar M.; Westhovens R.; van der Heijde D.; EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis  2020,79(6),685-699","journal-title":"Ann Rheum Dis"},{"key":"ref=7","first-page":"376","volume":"6","author":"Popescu C.","year":"2013","unstructured":"Popescu C.; Zofot\u0103 S.; Bojinc\u0103 V.; Ionescu R.; Anti- cyclic citrullinated peptide antibodies in psoriatic arthritis--cross-sectional study and literature review. J Med Life  2013,6(4),376-382","journal-title":"J Med Life"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1515\/CCLM.2007.027","volume":"45","author":"Bizzaro N.","year":"2007","unstructured":"Bizzaro N.; Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis. Clin Chem Lab Med  2007,45(2),150-157","journal-title":"Clin Chem Lab Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"Burmester G.R.","year":"2017","unstructured":"Burmester G.R.; Pope J.E.; Novel treatment strategies in rheumatoid arthritis. Lancet  2017,389(10086),2338-2348","journal-title":"Lancet"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","volume":"75","author":"Gossec L.","year":"2016","unstructured":"Gossec L.; Smolen J.S.; Ramiro S.; de Wit M.; Cutolo M.; Dougados M.; Emery P.; Landew\u00e9 R.; Oliver S.; Aletaha D.; Betteridge N.; Braun J.; Burmester G.; Ca\u00f1ete J.D.; Damjanov N.; FitzGerald O.; Haglund E.; Helliwell P.; Kvien T.K.; Lories R.; Luger T.; Maccarone M.; Marzo-Ortega H.; McGonagle D.; McInnes I.B.; Olivieri I.; Pavelka K.; Schett G.; Sieper J.; van den Bosch F.; Veale D.J.; Wollenhaupt J.; Zink A.; van der Heijde D.; European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis  2016,75(3),499-510","journal-title":"Ann Rheum Dis"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/BOR.0000000000000274","volume":"28","author":"Ritchlin C.T.","year":"2016","unstructured":"Ritchlin C.T.; Krueger J.G.; New therapies for psoriasis and psoriatic arthritis. Curr Opin Rheumatol  2016,28(3),204-210","journal-title":"Curr Opin Rheumatol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/0929867324666170426095015","volume":"25","author":"Cau Y.","year":"2018","unstructured":"Cau Y.; Valensin D.; Mori M.; Draghi S.; Botta M.; Structure, function, involvement in diseases and targeting of 14-3-3 proteins: an update. Curr Med Chem  2018,25(1),5-21","journal-title":"Curr Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1186\/ar4547","volume":"16","author":"Maksymowych W.P.","year":"2014","unstructured":"Maksymowych W.P.; van der Heijde D.; Allaart C.F.; Landew\u00e9 R.; Boire G.; Tak P.P.; Gui Y.; Ghahary A.; Kilani R.; Marotta A.; 14-3-3\u03b7 is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage. Arthritis Res Ther  2014,16(2),R99","journal-title":"Arthritis Res Ther"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"110611","DOI":"10.1016\/j.clinbiochem.2023.110611","volume":"118","author":"Do\u011fan \u0130.","year":"2023","unstructured":"Do\u011fan \u0130.; Kor A.; G\u00fcven S.C.; F\u0131rat O\u011fuz E.; Ba\u015fer S.; Atalar E.; Mara\u015f Y.; Erel \u00d6.; Erten \u015e.; 14\u20133-3 \u03b7 ETA protein as a potential marker of joint damage in gout. Clin Biochem  2023,118,110611","journal-title":"Clin Biochem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/1756-185X.13921","volume":"23","author":"Wang D.","year":"2020","unstructured":"Wang D.; Cui Y.; Lei H.; Cao D.; Tang G.; Huang H.; Yuan T.; Rao L.; Mo B.; Diagnostic accuracy of 14-3-3 \u03b7 protein in rheumatoid arthritis: A meta-analysis. Int J Rheum Dis  2020,23(11),1443-1451","journal-title":"Int J Rheum Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1080\/14397595.2019.1637575","volume":"30","author":"Hammam N.","year":"2020","unstructured":"Hammam N.; Salah S.; Kholef E.F.; Moussa E.M.; Marotta A.; 14-3-3\u03b7 Protein in serum and synovial fluid correlates with radiographic damage and progression in a longitudinal evaluation of patients with established rheumatoid arthritis. Mod Rheumatol  2020,30(4),664-670","journal-title":"Mod Rheumatol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/09674845.2020.1810400","volume":"78","author":"Hu T.","year":"2021","unstructured":"Hu T.; Liu Y.; Tan L.; Huang J.; Yu J.; Wu Y.; Pei Z.; Zhang X.; Li J.; Song L.; Dai W.; Xiang Y.; Value of serum collagen triple helix repeat containing-1(CTHRC1) and 14-3-3\u03b7 protein compared to anti-CCP antibodies and anti-MCV antibodies in the diagnosis of rheumatoid arthritis. Br J Biomed Sci  2021,78(2),67-71","journal-title":"Br J Biomed Sci"},{"key":"ref=18","first-page":"1650","volume":"34","author":"Kilani R.T.","year":"2007","unstructured":"Kilani R.T.; Maksymowych W.P.; Aitken A.; Boire G.; St-Pierre Y.; Li Y.; Ghahary A.; Detection of high levels of 2 specific isoforms of 14-3-3 proteins in synovial fluid from patients with joint inflammation. J Rheumatol  2007,34(8),1650-1657","journal-title":"J Rheumatol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1111\/1756-185X.14004","volume":"23","author":"Wei J.C.C.","year":"2020","unstructured":"Wei J.C.C.; Leong P.Y.; Liu G.Y.; Chaperone\/scaffolding\/adaptor protein 14-3-3\u03b7 (eta): A diagnostic marker of rheumatoid arthritis. Int J Rheum Dis  2020,23(11),1439-1442","journal-title":"Int J Rheum Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"Aletaha D.","year":"2010","unstructured":"Aletaha D.; Neogi T.; Silman A.J.; Funovits J.; Felson D.T.; Bingham C.O.; Birnbaum N.S.; Burmester G.R.; Bykerk V.P.; Cohen M.D.; Combe B.; Costenbader K.H.; Dougados M.; Emery P.; Ferraccioli G.; Hazes J.M.W.; Hobbs K.; Huizinga T.W.J.; Kavanaugh A.; Kay J.; Kvien T.K.; Laing T.; Mease P.; M\u00e9nard H.A.; Moreland L.W.; Naden R.L.; Pincus T.; Smolen J.S.; Stanislawska-Biernat E.; Symmons D.; Tak P.P.; Upchurch K.S.; Vencovsk\u00fd J.; Wolfe F.; Hawker G.; 2010 rheumatoid arthritis classification criteria: An American college of rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum  2010,62(9),2569-2581","journal-title":"Arthritis Rheum"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"Taylor W.","year":"2006","unstructured":"Taylor W.; Gladman D.; Helliwell P.; Marchesoni A.; Mease P.; Mielants H.; Group C.S.; Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum  2006,54(8),2665-2673","journal-title":"Arthritis Rheum"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.berh.2014.10.004","volume":"28","author":"Machado P.M.","year":"2014","unstructured":"Machado P.M.; Raychaudhuri S.P.; Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis. Best Pract Res Clin Rheumatol  2014,28(5),711-728","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/14397595.2020.1812870","volume":"31","author":"Nas K.","year":"2021","unstructured":"Nas K.; Kili\u00e7 E.; Tekeo\u011flu \u0130.; Keskin Y.; \u00c7evik R.; Sargin B.; Acer Kasman S.; Alkan H.; Sahin N.; Cengiz G.; C\u00fczdan N.; Albayrak Gezer \u0130.; Keskin D.; M\u00fclkoglu C.; Re\u015forlu H.; Ataman \u015e.; Bal A.; Baykul M.; Duru\u00f6z M.T.; K\u00fc\u00e7\u00fckakka\u015f O.; Yurdakul O.V.; Alkan Meliko\u011flu M.; Ayhan F.F.; Bodur H.; \u00c7ali\u015f M.; \u00c7apkin E.; Devrimsel G.; G\u00f6k K.; Hizmetli S.; Kamanl\u0131 A.; Kocaba\u015f H.; Kutluk \u00d6.; \u015een N.; \u015eendur \u00d6.F.; Toprak M.; Tolu S.; Tuncer T.; The effect of gender on disease activity and clinical characteristics in patients with axial psoriatic arthritis. Mod Rheumatol  2021,31(4),869-874","journal-title":"Mod Rheumatol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00296-009-1353-1","volume":"31","author":"Garip Y.","year":"2011","unstructured":"Garip Y.; Eser F.; Bodur H.; Health-related quality of life in rheumatoid arthritis: comparison of RAQoL with other scales in terms of disease activity, severity of pain, and functional status. Rheumatol Int  2011,31(6),769-772","journal-title":"Rheumatol Int"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"Anderson J.","year":"2012","unstructured":"Anderson J.; Caplan L.; Yazdany J.; Robbins M.L.; Neogi T.; Michaud K.; Saag K.G.; O\u2019dell J.R.; Kazi S.; Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken)  2012,64(5),640-647","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref=26","unstructured":"Human 14-3-3 protein eta (YWHAH) ELISA kit. Available from:  https:\/\/www.cusabio.com\/ELISA-Kit\/Human-14-3-3-protein-etaYWHAH-ELISA-kit-112977.html#a05"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3906\/sag-1812-137","volume":"49","author":"Salman E.","year":"2019","unstructured":"Salman E.; \u00c7eti\u0307ner S.; Boral B.; Ki\u0307bar F.; Erken E.; Ers\u00f6zl\u00fc E.D.; Badak S.\u00d6.; Bi\u0307li\u0307ci\u0307 Salman R.; Sertdemi\u0307r Y.; \u00c7eti\u0307n Duran A.; Yaman A.; Importance of 14-3-3 eta, anti- CarP, and anti-Sa in the diagnosis of seronegative rheumatoid arthritis. Turk J Med Sci  2019,49(5),1498-1502","journal-title":"Turk J Med Sci"},{"key":"ref=28","first-page":"57","volume":"49","author":"Guan S.Z.","year":"2019","unstructured":"Guan S.Z.; Yang Y.Q.; Bai X.; Wang Y.; Feng K.Q.; Zhang H.J.; Dong M.; Yang H.W.; Li H.Q.; Serum 14-3-3\u03b7 could improve the diagnostic rate of rheumatoid arthritis and correlates to disease activity. Ann Clin Lab Sci  2019,49(1),57-62","journal-title":"Ann Clin Lab Sci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/annrheumdis-2019-216374","volume":"79","author":"Souto-Carneiro M.","year":"2020","unstructured":"Souto-Carneiro M.; T\u00f3th L.; Behnisch R.; Urbach K.; Klika K.D.; Carvalho R.A.; Lorenz H.M.; Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis. Ann Rheum Dis  2020,79(4),499-506","journal-title":"Ann Rheum Dis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1007\/s10067-017-3807-2","volume":"36","author":"Gong X.","year":"2017","unstructured":"Gong X.; Xu S.; Wu Y.; Ma C.; Qi S.; Liu W.; Xu J.; Elevated serum 14-3-3\u03b7 protein may be helpful for diagnosis of early rheumatoid arthritis associated with secondary osteoporosis in Chinese population. Clin Rheumatol  2017,36(11),2581-2587","journal-title":"Clin Rheumatol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3899\/jrheum.131446","volume":"41","author":"Maksymowych W.P.","year":"2014","unstructured":"Maksymowych W.P.; Naides S.J.; Bykerk V.; Siminovitch K.A.; van Schaardenburg D.; Boers M.; Landew\u00e9 R.; van der Heijde D.; Tak P.P.; Genovese M.C.; Weinblatt M.E.; Keystone E.C.; Zhukov O.S.; Abolhosn R.W.; Popov J.M.; Britsemmer K.; van Kuijk A.W.; Marotta A.; Serum 14-3-3\u03b7 is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis. J Rheumatol  2014,41(11),2104-2113","journal-title":"J Rheumatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13075-016-0935-z","volume":"18","author":"Carrier N.","year":"2016","unstructured":"Carrier N.; Marotta A.; de Brum-Fernandes A.J.; Liang P.; Masetto A.; M\u00e9nard H.A.; Maksymowych W.P.; Boire G.; Serum levels of 14-3-3\u03b7 protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis. Arthritis Res Ther  2016,18(1),37","journal-title":"Arthritis Res Ther"},{"key":"ref=33","first-page":"1899","volume":"23","author":"Qu C.H.","year":"2019","unstructured":"Qu C.H.; Hou Y.; Bi Y.F.; Han Q.R.; Jiao C.H.; Zou Q.F.; Diagnostic values of serum IL-10 and IL-17 in rheumatoid arthritis and their correlation with serum 14-3-3\u03b7 protein. Eur Rev Med Pharmacol Sci  2019,23(5),1899-1906","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3899\/jrheum.141385","volume":"42","author":"Maksymowych W.P.","year":"2015","unstructured":"Maksymowych W.P.; Boire G.; van Schaardenburg D.; Wichuk S.; Turk S.; Boers M.; Siminovitch K.A.; Bykerk V.; Keystone E.; Tak P.P.; van Kuijk A.W.; Landew\u00e9 R.; van der Heijde D.; Murphy M.; Marotta A.; 14-3-3\u03b7 autoantibodies: diagnostic use in early rheumatoid arthritis. J Rheumatol  2015,42(9),1587-1594","journal-title":"J Rheumatol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13075-015-0799-7","volume":"17","author":"Hirata S.","year":"2015","unstructured":"Hirata S.; Marotta A.; Gui Y.; Hanami K.; Tanaka Y.; Serum 14-3-3\u03b7 level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab. Arthritis Res Ther  2015,17(1),280","journal-title":"Arthritis Res Ther"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"582","DOI":"10.34172\/aim.2023.85","volume":"26","author":"Kor A.","year":"2023","unstructured":"Kor A.; Yal\u00e7\u0131n M.; Erten \u015e.; Mara\u015f Y.; O\u011fuz E.F.; Do\u011fan \u0130.; Atalar E.; Ba\u015fer S.; Erel \u00d6.; 14-3-3\u03b7 proteins as a diagnostic marker, disease activation indicator, and lymphoma predictor in patients with primary sj\u00f6gren syndrome. Arch Iran Med  2023,26(10),582-591","journal-title":"Arch Iran Med"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673295359240422115759","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/229468\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673295359240422115759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T09:36:05Z","timestamp":1733736965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/229468\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":36,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673295359240422115759","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-11-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}